<DOC>
	<DOCNO>NCT01202266</DOCNO>
	<brief_summary>The primary purpose study evaluate safety , tolerability pharmacokinetics multiple escalate oral dos PF-05161704 healthy volunteer</brief_summary>
	<brief_title>A Multiple Dose Study Of PF-05161704 In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male and/or female ( nonchildbearing potential ) subject age 18 55 year , inclusive Body Mass Index ( BMI ) 24.5 35.5 kg/m2 total body weight &gt; 50 kg ( 110 lb . ) Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( e.g. , gastrectomy ) . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month screen . History evidence habitual use tobacco nicotine containing product within 3 month screen positive cotinine test screen Day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Multiple Ascending Dose</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Safety Tolerability</keyword>
	<keyword>PK</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>